105 résultats
200764015Washington DC: U.S. Government Printing Office 2007. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. iii 213 p. Occasional footnotes. Tables. Serial No. 109-232. The Committee found that determining the total amoung of funding for the global war on terrorism was challenging because of the various ways in which funds were appropriated and the failure of the Department of Defense to have auditable financial statements. U.S. Government Printing Office paperback
2012SONG1782662693www.Militarybookshop.Co.UK 2012-12-01. hardcover. Used: Good. 8.50x0.56x11.00. Buy with confidence. Excellent Customer Service & Return policy. www.Militarybookshop.Co.UK hardcover
20152090502113708969Not Available 2015. Soft Cover. Fine. The book is in fine condition. Not Available paperback
20052110502150400403Nihonhyoronsha 2005. Soft Cover. Fine. Volume: 1 Nihonhyoronsha paperback
200461978Washington DC: U. S. Government Printing Office 2004. Presumed first edition/first printing. Wraps. Very good. No dust jacket as issued. iii 588 p. Illustrations. Serial No. 108-206. This hearing examins the latest medical science regarding cervical cancer and ongoing Federal efforts to treat the disease and prevent infection from the virus that causes it. U. S. Government Printing Office paperback
200364416Washington DC: U.S. Government Printing Office 2003. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. iii 206 p. Serial No. 107-156. This is the record of hearings that were part of the process of assessing the impacts of the September 11th attacks and the federal response to them. U.S. Government Printing Office paperback
200763262Washington DC: U.S. Government Printing Office 2007. Presumed first edition/first printing. Wraps. Very Good. No dust jacket as issued. iii 213 p. Occasional footnotes. Serial No. 109-232. U.S. Government Printing Office paperback
200566635Washington DC: U. S. Government Printing Office 2005. Presumed first edition/first printing. Wraps. Good. No dust jacket. iii 352 p. Title continues: One Hundred Eighth Congress Second Session April 1 2004. Serial No. 108-226. From Wilipedia: Medical Marajuana "Medical cannabis refers to the parts of the herb cannabis used as a physician-recommended form of medicine or herbal therapy or to synthetic forms of specific cannabinoids such as THC as a physician-recommended form of medicine. The Cannabis plant has a long history of use as medicine with historical evidence dating back to 2737 BCE. Cannabis is one of the 50 "fundamental" herbs of traditional Chinese medicine and is prescribed for a broad range of indications. One of the major criticisms of cannabis as medicine is opposition to smoking as a method of consumption. However smoking is no longer necessary due to the development of healthier methods. Today medicinal cannabis patients can use vaporizers where the essential cannabis compounds are extracted and inhaled. In addition edible cannabis which is produced in various baked goods is also available and has demonstrated longer lasting effects. The United States Food and Drug Administration FDA issued an advisory against smoked medical cannabis stating that "marijuana has a high potential for abuse has no currently accepted medical use in treatment in the United States and has a lack of accepted safety for use under medical supervision. The National Institute on Drug Abuse NIDA state that "Marijuana itself is an unlikely medication candidate for several reasons: 1 it is an unpurified plant containing numerous chemicals with unknown health effects; 2 it is typically consumed by smoking further contributing to potential adverse effects; and 3 its cognitive impairing effects may limit its utility". The Institute of Medicine run by the United States National Academy of Sciences conducted a comprehensive study in 1999 to assess the potential health benefits of cannabis and its constituent cannabinoids. The study concluded that smoking cannabis is not recommended for the treatment of any disease condition but did conclude that nausea appetite loss pain and anxiety can all be mitigated by marijuana. While the study expressed reservations about smoked cannabis due to the health risks associated with smoking the study team concluded that until another mode of ingestion was perfected that could provide the same relief as smoked cannabis there was no alternative. In addition the study pointed out the inherent difficulty in marketing a non-patentable herb. Pharmaceutical companies will not substantially profit unless there is a patent. For those reasons the Institute of Medicine concluded that there is little future in smoked cannabis as a medically approved medication. The report also concluded that for certain patients such as the terminally ill or those with debilitating symptoms the long-term risks are not of great concern. Marinol was less effective than the steroid megestrol in helping cancer patients regain lost appetites. A phase III study found no difference in effects of an oral cannabis extract or THC on appetite and quality of life QOL in patients with cancer-related anorexia-cachexia syndrome CACS to placebo. "Citing the dangers of cannabis and the lack of clinical research supporting its medicinal value" the American Society of Addiction Medicine in March 2011 issued a white paper recommending a halt to using marijuana as a medicine in U.S. states where it has been declared legal." U. S. Government Printing Office paperback
200461678Washington DC: U. S> Government Printing Office 2004. Presumed first edition/first printing. Hardcover. Good. No dust jacket as issued. iii 508 p. Illustrations. Serial No. 108-276. This hearing was held at Kailua-Kona Hawaii. This hearing is a continuation of the subcommittee's work on the problem of methamphetamine abuse--a problem that was ravaging the State of Hawaii and other parts of the United States. Meth in Hawaii came from superlabs in California and Mexico and from small local laboratories. The hearing sought to address "Firstly what to we need to do to reduce the supply of meth " and "Second how shouldwe deal with the environmental issues created in the wake of a meth lab seizure " U. S> Government Printing Office hardcover
200548498Washington DC: GPO 2005 & 2006. First Edition. First Printing. good. 163 & 117 Parts I and II wraps table appendix. Serial No. 108-259 and 109-105. Part I of the hearing was held on August 2 2004; Part II was held on October 31 2005. GPO paperback
200245362Washington DC: GPO 2002. First Edition. First Printing. good. 672 wraps stiff paper covers illus. GPO paperback
20092083002115704694Nihonhyoronsha 2009. Soft Cover. Fine. Number of pages: x 365p Size: 22cm Number of books: 1 Nihonhyoronsha paperback
2006mon0000408381Rowman & Littlefield Publishers 2006-12-13. Hardcover. Very Good. 0.5000 in x 9.1000 in x 6.0000 in. Rowman & Littlefield Publishers hardcover
20012080502106908578Guanxi University Economics and Politics Research Book 2001. Soft Cover. Fine. The book is in fine condition. Guanxi University Economics and Politics Research Book paperback
20011331686PN. New. 2001. Soft Cover. Date is original print. This is a reprint edition . PN paperback
200662284Washington DC: U. S. Government Printing Office 2006. Presumed first edition/first printing. Hardcover. Very good. No dust jacket as issued. iv 438 p. Occasional footnotes. Serial No. 109-150. Hearing held on February 14 2006. The Congressional perspective is illustrated by the Chairman's statement that "Seldom in our history has the need for the whiltleblower's unfiltered voice been more urgent particularly in the realms of national security and intelligence. " U. S. Government Printing Office hardcover
200366652Washington DC: U. S. Government Printing Office 2003. Presumed first edition/first printing. Wraps. Very good. No dust jacket. iii 305 p. Illustrations. Title continues: Second Session February 22 2002. Serial No. 107-148. The subcommittee held this hearing to explore the status of the border crossings in the Southeast Arizona region. The subcommittee was considering ways to improve both the security of the borders and the efficient flow of international commerce travel and tourism. U. S. Government Printing Office paperback
200251075Washington DC: GPO 2002. First Edition. First Printing. very good. 524 wraps footnotes appendices. Serial No. 107-73. This hearing includes testimony from several noted presidential historians including Robert Dallak Stanley Kutler and Richard Reeves. GPO paperback
2001Q-1563089459Libraries Unlimited 2001-10-15. Paperback. New. In shrink wrap. Looks like an interesting title! Libraries Unlimited paperback
200851592Washington DC: GPO 2008. very good. 321 wraps figures footnotes Serial No. 110-81. This hearing examines the question: when companies fail to perform should they give millions of dollars to their senior executives The CEO's of Countrywide Financial Corp. Merrill Lynch and Citigroup testified. GPO paperback
20072081502111903284china statistics 2007. Soft Cover. Fine. The book is in fine condition. china statistics paperback
2007230321TRW011069London: Electoral Reform Society 2007. Softcover. Good Condition. Library sticker on front cover. Pages are unmarked and uncreased. Bindings and spine firm and intact. Otherwise in very good used condition. 144 pp. Shipped Weight: Under 1 kilo. Category: Politics & Government; Great Britain; Elections; ISBN: 0903291355. ISBN/EAN: 9780903291354. Add. Inventory No: 230321TRW011069. . 9780903291354 Electoral Reform Society paperback
200351787Place_Pub: Washington DC: GPO 2003. very good. 340 wraps footnotes tables. Serial No. 107-155. An examination of the Office of Management and Budget's annual regulatory accounting reports which disclose the off-budget costs and benefits associated with Federal regulations and paperwork. GPO paperback
20092111902152904841Nobuyama-sha 2009. Soft Cover. Fine. Size: A5 size Nobuyama-sha paperback
200161959Washington DC: U. S. Government Printing Office 2001. Presumed first edition/first printing. Wraps. Very good. No dust jacket as issued. Cover has minor wear and soiling. iv 1104 p. Some portions redacted. Serial No. 106-179. The hearings explored the failure of the White House to provide documents requested by the committee. U. S. Government Printing Office paperback
